Dick Allen Biography and Net Worth



Mr. Allen has served as a member of our board of directors since July 2007.  He previously served as Lead Independent Director from March 2019 to February 2023, and as Chair of our board of directors from August 2007 to January 2013 and from January 2016 to February 2019. Mr. Allen is directly engaged in the diabetes community through his personal involvement with JDRF, a nonprofit diabetes research organization, and the Mary & Dick Allen Diabetes Center at Hoag Memorial Hospital Presbyterian. Mr. Allen served as a member of the International Board of Directors of JDRF from July 2008 to June 2014, and as its Chair from July 2012 to June 2014. Mr. Allen has more than 50 years of experience in the health care industry and was previously the President of DIMA Ventures, Inc., a private investment firm providing seed capital and board-level support for start-up companies in the healthcare field. He was a co-founder and Vice President of Caremark, Inc., a home infusion therapy company later acquired by Baxter International. He was also a co-founder and director of Pyxis Corporation, later acquired by Cardinal Health, Inc. Mr. Allen received a B.S. (cum laude) in Industrial Administration from Yale University and an M.B.A. from Stanford University Graduate School of Business where he served on the faculty as a Lecturer in Strategic Management for 13 years.

What is Dick Allen's net worth?

The estimated net worth of Dick Allen is at least $479,625.36 as of May 30th, 2024. Mr. Allen owns 24,396 shares of Tandem Diabetes Care stock worth more than $479,625 as of March 27th. This net worth evaluation does not reflect any other assets that Mr. Allen may own. Learn More about Dick Allen's net worth.

How do I contact Dick Allen?

The corporate mailing address for Mr. Allen and other Tandem Diabetes Care executives is 11075 ROSELLE STREET, San Diego CA, 92121. Tandem Diabetes Care can also be reached via phone at (858) 366-6900 and via email at smorrison@tandemdiabetes.com. Learn More on Dick Allen's contact information.

Has Dick Allen been buying or selling shares of Tandem Diabetes Care?

Dick Allen has not been actively trading shares of Tandem Diabetes Care during the last quarter. Most recently, Dick Allen sold 5,000 shares of the business's stock in a transaction on Thursday, May 30th. The shares were sold at an average price of $51.68, for a transaction totalling $258,400.00. Following the completion of the sale, the director now directly owns 24,396 shares of the company's stock, valued at $1,260,785.28. Learn More on Dick Allen's trading history.

Who are Tandem Diabetes Care's active insiders?

Tandem Diabetes Care's insider roster includes Dick Allen (Director), David Berger (EVP), Kim Blickenstaff (Director), Elizabeth Gasser (EVP), Brian Hansen (EVP), Shannon Hansen (Executive Vice President, Chief Legal, Privacy and Compliance Officer and Secretary), Jean-Claude Kyrillos (Executive Vice President and Chief Operating Officer), James Leal (SVP), Kathleen McGroddy-Goetz (Director), Susan Morrison (EVP), Mark Novara (Executive Vice President and Chief Commercial Officer), Rebecca Robertson (Director), John Sheridan (CEO), Christopher Twomey (Director), and Leigh Vosseller (CFO). Learn More on Tandem Diabetes Care's active insiders.

Are insiders buying or selling shares of Tandem Diabetes Care?

In the last twelve months, Tandem Diabetes Care insiders bought shares 2 times. They purchased a total of 11,070 shares worth more than $203,312.24. In the last twelve months, insiders at the medical device company sold shares 3 times. They sold a total of 25,000 shares worth more than $858,400.00. The most recent insider tranaction occured on March, 7th when COO Jean-Claude Kyrillos bought 10,538 shares worth more than $190,948.56. Insiders at Tandem Diabetes Care own 2.2% of the company. Learn More about insider trades at Tandem Diabetes Care.

Information on this page was last updated on 3/7/2025.

Dick Allen Insider Trading History at Tandem Diabetes Care

See Full Table

Dick Allen Buying and Selling Activity at Tandem Diabetes Care

This chart shows Dick Allen's buying and selling at Tandem Diabetes Care by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200k$0$200kTotal Insider BuyingTotal Insider Selling

Tandem Diabetes Care Company Overview

Tandem Diabetes Care logo
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $19.66
Low: $19.12
High: $20.30

50 Day Range

MA: $28.75
Low: $17.89
High: $37.53

2 Week Range

Now: $19.66
Low: $17.64
High: $53.69

Volume

976,019 shs

Average Volume

1,458,898 shs

Market Capitalization

$1.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.45